Diabetic Glomerulonephropathy

Overview


Plain-Language Overview

Diabetic Glomerulonephropathy is a kidney condition that occurs in people with diabetes. It affects the glomeruli, which are tiny filtering units in the kidneys responsible for cleaning the blood. Over time, high blood sugar levels damage these filters, causing them to become thickened and scarred. This damage leads to protein leakage into the urine, which is an early sign of kidney problems. As the disease progresses, it can reduce the kidneys' ability to filter waste, potentially leading to kidney failure. Managing blood sugar and blood pressure is important to slow this damage. This condition is a common cause of chronic kidney disease in diabetic patients.

Clinical Definition

Diabetic Glomerulonephropathy is a microvascular complication of diabetes mellitus characterized by progressive damage to the renal glomeruli. The core pathology involves mesangial expansion, glomerular basement membrane thickening, and nodular glomerulosclerosis (Kimmelstiel-Wilson lesions) due to chronic hyperglycemia-induced metabolic and hemodynamic changes. These changes lead to increased glomerular permeability and proteinuria, which is a hallmark clinical feature. The condition is a leading cause of end-stage renal disease (ESRD) worldwide. Pathogenesis includes advanced glycation end products, activation of the renin-angiotensin-aldosterone system, and oxidative stress. Clinically, it manifests as persistent albuminuria, declining glomerular filtration rate, and hypertension.

Inciting Event

Locked content

Latency Period

Locked content

Diagnostic Delay

Locked content

Clinical Presentation


Signs & Symptoms

Locked content

History of Present Illness

Locked content

Past Medical History

Locked content

Family History

Locked content

Physical Exam Findings

Locked content

Diagnostic Workup


Diagnostic Criteria

Locked content

Pathophysiology


Key Mechanisms

Locked content

Organs

Locked content

Tissues

Locked content

Cells

Locked content

Chemical Mediators

Locked content

Treatments


Pharmacological Treatments

Locked content

Non-pharmacological Treatments

Locked content

Prevention


Pharmacological Prevention

Locked content

Non-pharmacological Prevention

Locked content

Outcome & Complications


Complications

Locked content

Short-term Sequelae

Locked content

Long-term Sequelae

Locked content

Differential Diagnoses


Differentials

Locked content

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.